Title : Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers.

Pub. Date : 2012 Apr

PMID : 21821547






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers. Paclitaxel cyclin dependent kinase 1 Homo sapiens